56/100

Moderate evidence

Cite
More
EmailLinkedInX

AI matched standard lung scan alignment tools on 10 test patients and ran faster

Study title: Comparative evaluation of VoxelMorpand conventional deformable image registration algorithms for thoracic 4D-CT in radiotherapy

Evidence type
Observational study
Sample
n = 64
Sources
1 sourcePeer-reviewed
Published
1 min read

Study title: Comparative evaluation of VoxelMorpand conventional deformable image registration algorithms for thoracic 4D-CT in radiotherapy

Researchers retrospectively evaluated VoxelMorph deep learning deformable registration on thoracic 4D-CT from 64 lung cancer patients, training on 50 cases and testing on 10 against Demons, modified Demons, and ANACONDA using end-inhalation to end-exhalation registration.

Read the study abstract

Background Deformable image registration (DIR) is essential for thoracic four-dimensional computed tomography (4D-CT)-based radiotherapy applications. Recently, deep learning-based DIR methods such as VoxelMorph have been proposed; however, their performance relative to clinically used DIR algorithms remains unclear. Purpose This study aimed to evaluate the DIR accuracy of VoxelMorph for thoracic 4D-CT and to compare it with conventional clinical and research-oriented DIR methods. Materials and methods Thoracic…

Comparative evaluation of VoxelMorpand conventional deformable image registration algorithms for thoracic 4D-CT in radiotherapy
Metastatic prostatic adenocarcinoma - CT scan - Case 257 (8519047084) by Yale Rosen from USA. CC BY-SA 2.0 · https://creativecommons.org/licenses/by-sa/2.0

The gain

On 10 test lung cancer patients, VoxelMorph cut median CT-value error from 67.56 to 36.83 HU, close to ANACONDA (36.18) and Demons (37.39), with a median lung overlap of 0.98 and shorter processing time.

In brief

By the October 2026 publication date, the test results showed VoxelMorph achieving comparable accuracy to clinical tools with high lung overlap and reduced processing time in this implementation, but the authors noted that broader standardized validation is still needed to support routine radiotherapy use.

Main points

  1. Retrospective analysis used thoracic 4D-CT from 64 lung cancer patients, with end-inhalation and end-exhalation phases for registration.
  2. VoxelMorph was trained on 50 cases, validated on 4, and tested on 10, compared against Demons (SimpleITK), modified Demons (Eclipse), and ANACONDA (RayStation).
  3. Accuracy metrics were MAE of CT values within body region, and DSC and HD95 within lung label, with median HD95 of 2.5 mm for VoxelMorph versus 2.0 mm for ANACONDA.

The full story

The study used end-inhalation and end-exhalation images from 64 lung cancer patients, splitting 50 for training VoxelMorph, 4 for validation, and 10 for testing against three conventional methods.

On the 10-case test set, median MAE fell from 67.56 HU pre-registration to 36.83 HU with VoxelMorph, compared to 36.18 HU for ANACONDA and 37.39 HU for Demons, while median DSC rose to 0.98 and median HD95 was 2.5 mm.

Sources

1 on file
  1. Peer-reviewed2026-10-01

Talk it over

Three questions to start on, two more if you have time
VoxelMorph cut median CT-value error from 67.56 to 36.83 HU, close to ANACONDA at 36.18 and Demons at 37.39. How much does faster processing matter to you at that level of accuracy?

Start with a question

AI matched standard lung scan alignment tools on 10 test patients and ran fasterhttps://truvace.com/item/comparative-evaluation-of-voxelmorpand-conventional-deformable-image-registratio

  1. VoxelMorph cut median CT-value error from 67.56 to 36.83 HU, close to ANACONDA at 36.18 and Demons at 37.39. How much does faster processing matter to you at that level of accuracy?

    Answer in the thread
  2. The test covered only 10 patients, drawn from one retrospective cohort of 64 lung cancer patients. How many more patients, and from where, would you want in a test before trusting the comparison with ANACONDA and Demons?

    Answer in the thread
  3. Median HD95 was 2.5 mm for VoxelMorph and 2.0 mm for ANACONDA. What result in a larger test would settle whether that gap matters for radiotherapy planning?

    Answer in the thread
If you have more time
  • The authors said broader standardized validation is still needed. Who should run it, and which hospitals or scanners should it include?

    Answer in the thread
  • Look up how much processing time VoxelMorph saved. How would that matter in a radiotherapy department you know, and for which patients?

    Answer in the thread

What readers say